Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial

被引:29
|
作者
Algera, Joost P. [1 ]
Demir, Dagsu [1 ]
Tornblom, Hans [1 ]
Nybacka, Sanna [1 ]
Simren, Magnus [1 ,2 ]
Storsrud, Stine [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, S-40530 Gothenburg, Sweden
[2] Univ N Carolina, Ctr Funct GI & Motil Disorders, Chapel Hill, NC 27515 USA
基金
瑞典研究理事会;
关键词
IBS; Fermentable oligosaccharides disaccharides  monosaccharides and polyols; FODMAP; NICE guidelines; Gastrointestinal symptoms; Predictors of response; VISCERAL SENSITIVITY; GLUTEN; GUIDELINES; MANAGEMENT; FRUCTAN; ANXIETY; ADULTS; SCALE;
D O I
10.1016/j.clnu.2022.11.001
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Fermentable oligo-, di-, monosaccharides and polyols (FODMAPs) can provoke symptoms in patients with irritable bowel syndrome (IBS). We aimed to compare the effects of diets with low vs. moderate FODMAP content on gastrointestinal (GI) symptoms and bowel habits, and to identify possible predictors of clinical response to a low FODMAP diet and FODMAP sensitivity in IBS. Methods: Adult participants with IBS (Rome IV criteria, n = 29) were included and adhered to two 7-day diet periods, with either low (4 g/day) or moderate (23 g/day) amounts of FODMAPs, in this randomized, double-blind, crossover study. The periods were separated by a wash-out period (>= 14 days). IBS-Severity Scoring System (IBS-SSS) and a stool diary (Bristol Stool Form) were completed before and after the diet periods. At baseline, severity of GI symptoms and gut microbial fermentation were assessed (every 15 min, 4 h) during the Lactulose Nutrient Challenge Test (LNCT). Clinical response and FODMAP sensitivity were defined by reduction after low FODMAP period, and increase after moderate FODMAP period in IBS-SSS (>= 50 points), respectively.Results: Severity of GI symptoms (P = 0.04), stool consistency (P = 0.01), and stool frequency (P = 0.01) differed between the interventions, with reduced overall GI symptom severity, abdominal pain intensity and frequency, bowel habits dissatisfaction, and daily life interference (P < 0.05 for all), as well as more firm (P = 0.03) and less frequent (P < 0.01) stools after low FODMAP intervention, but not after moderate FODMAP intervention. A third (34%) responded clinically to the low FODMAP diet, and the response could be predicted by higher IBS-SSS at baseline (P = 0.02). Although modest associations between FODMAP sensitivity (22%) and GI symptoms during LNCT were observed, no independent predictors could be identified.Conclusions: A diet low in FODMAPs reduces GI symptoms and affects bowel habits in IBS, compared with a moderate FODMAP diet. Assessment of IBS severity before the intervention may be used to predict clinical response to a low FODMAP diet.Trial registry (http://www.clinicaltrials.gov): Registered under Clinical Trial number NCT05182593.(c) 2022 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:2792 / 2800
页数:9
相关论文
共 50 条
  • [1] Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial
    Tao, Linghui
    Du, Fei
    CLINICAL NUTRITION, 2023, 42 (04) : 613 - 613
  • [2] Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity
    Algera, Joost P.
    Demir, Dagsu
    Tornblom, Hans
    Nybacka, Sanna
    Simren, Magnus
    Storsrud, Stine
    CLINICAL NUTRITION, 2023, 42 (04) : 611 - 612
  • [3] Supplementing Dietary Fibers With a Low FODMAP Diet in Irritable Bowel Syndrome: A Randomized Controlled Crossover Trial
    So, Daniel
    Yao, Chu K.
    Ardalan, Zaid S.
    Thwaites, Phoebe A.
    Kalantar-Zadeh, Kourosh
    Gibson, Peter R.
    Muir, Jane G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (09) : 2112 - +
  • [4] Investigating the Role of Low-FODMAP Diet in Improving Gastrointestinal Symptoms in Irritable Bowel Syndrome
    Yang, Jiahong
    Lin, Gina Ziruo
    Li, Xiao Ying
    Wang, Yu Tien
    Loh, Yet Hua
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2022, 31
  • [5] Gastrointestinal symptoms and dietary intake of patients with irritable bowel syndrome following a low FODMAP diet
    不详
    LAEKNABLADID, 2024, 110 (06): : 11 - 17
  • [6] The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study
    de Roest, R. H.
    Dobbs, B. R.
    Chapman, B. A.
    Batman, B.
    O'Brien, L. A.
    Leeper, J. A.
    Hebblethwaite, C. R.
    Gearry, R. B.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (09) : 895 - 903
  • [7] Low FODMAP diet reduces irritable bowel symptoms and improves quality of life in patients with inflammatory bowel disease in a randomized controlled trial
    Pedersen, N.
    Felding, M.
    Ankersen, D.
    Vegh, Z.
    Burisch, J.
    Munkholm, P.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S47 - S47
  • [8] Low FODMAP Diet Reduces Irritable Bowel Symptoms and Improves Quality of Life in Patients With Inflammatory Bowel Disease in a Randomized Controlled Trial
    Pedersen, Natalia
    Ankersen, Dorit V.
    Felding, Maria
    Vegh, Zsuzsanna
    Burisch, Johan
    Munkholm, Pia
    GASTROENTEROLOGY, 2014, 146 (05) : S587 - S587
  • [9] Low FODMAP diet & prebiotic β-galactooligosaccharides improve irritable bowel syndrome and response to low FODMAP is predicted by urine and faecal metabolites: a randomised controlled trial
    Wilson, B.
    Rossi, M.
    Kanno, T.
    Hough, R.
    Probert, C.
    Parkes, G.
    Anderson, S.
    Irving, P.
    Mason, A. J.
    Lomer, M. C.
    Whelan, K.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2020, 79 (OCE1) : E19 - E19
  • [10] β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria
    Wilson, Bridgette
    Rossi, Megan
    Kanno, Tokuwa
    Parkes, Gareth C.
    Anderson, Simon
    Mason, A. James
    Irving, Peter M.
    Lomer, Miranda C.
    Whelan, Kevin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (06): : 906 - 915